Marlborough

The U.S. Department of Veterans Affairs (VA) purchased an additional 20 ReWalk exoskeleton units from the Marlborough company to support initiation of their national multi-center clinical trial.

Marlborough's Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for two catheters that can be used with the company's Rhythmia Mapping System.

The biopharma industry in Central Massachusetts is hiring at a record rate, with job listings throughout Worcester and the 495 more than doubling in the first quarter of 2016.

The Marlborough company that has created sport cleats for more than half a century has rebranded itself to mark its anniversary.

Marlborough's Boston Scientific posted $1.964 billion in sales in its first quarter, eclipsing the company's guidance and representing 13 percent year-over-year growth.

Marlborough contract manufacturer Web Industries will unveil its new 25,000-square-foot Holliston facility on Thursday.

The latest machine from Hologic that has been approved for commercial use by the FDA could help doctors fight breast cancer by combining 3d technology with better access to the patient.

A new meta-study has found that 76 percent of patients involved in numerous studies of the ReWalk exoskeleton system were ultimately able to walk with no help from anyone else.

The towns and cities of Central Massachusetts have received $42.4 million in funding towards road projects from the state.

Marlborough's Boston Biomedical Associates (BBA) has achieved premarket approval from the FDA for Boston-based CardioFocus' laser therapy that treats irregular heartbeats caused by atrial fibrillation.